Search

Your search keyword '"GADA, HEMAL"' showing total 174 results
Start Over Author "GADA, HEMAL" Publication Year Range Last 3 years
174 results on '"GADA, HEMAL"'

3. Abstract 4144096: Outcomes of Left Atrial Appendage Occlusion in Patients with Atrial Fibrillation and Gastrointestinal Bleeding: Insights from a Multicenter Registry

Author

Ayub, Muhammad Talha, Preisendorfer, Stefan, Wann, Dan, Howard, Ato, Thoma, Floyd, Zhu, Jianhui, Sheth, Aakash, Jabbour, George, Singh, Madhurmeet, patel, chinmay, Gada, Hemal, Bhonsale, Aditya, Estes, Nathan, Kancharla, Krishna, Shalaby, Alaa, Singla, Virginia, Naniwadekar, Aditi, Voigt, Andrew, Saba, Samir, and Jain, Sandeep

Published
2024
Full Text
View/download PDF

4. Three-Year Outcomes Following TAVR in Younger (<75 Years) Low-Surgical-Risk Severe Aortic Stenosis Patients

Author

Modine, Thomas, Tchétché, Didier, Van Mieghem, Nicolas M., Deeb, G. Michael, Chetcuti, Stanley J., Yakubov, Steven J., Sorajja, Paul, Gada, Hemal, Mumtaz, Mubashir, Ramlawi, Basel, Bajwa, Tanvir, Crouch, John, Teirstein, Paul S., Kleiman, Neal S., Iskander, Ayman, Bagur, Rodrigo, Chu, Michael W.A., Berthoumieu, Pierre, Sudre, Arnaud, Adrichem, Rik, Ito, Saki, Huang, Jian, Popma, Jeffrey J., Forrest, John K., and Reardon, Michael J.

Published
2024
Full Text
View/download PDF

5. Use and performance of the evolut FX transcatheter aortic valve system

Author

Bajwa, Tanvir, Attizzani, Guilherme F., Gada, Hemal, Chetcuti, Stanley J., Williams, Mathew R., Ahmed, Mustafa, Petrossian, George A., Saybolt, Matthew D., Allaqaband, Suhail Q., Merhi, William M., Stoler, Robert C., Bezerra, Hiram, Mahoney, Paul, Wu, Willis, Jumper, Robert, Lambrecht, Larry, and Tang, Gilbert H.L.

Published
2024
Full Text
View/download PDF

11. 1-Year Outcomes From the CLASP IID Randomized Trial for Degenerative Mitral Regurgitation

Author

Zahr, Firas, Smith, Robert L., Gillam, Linda D., Chadderdon, Scott, Makkar, Raj, von Bardeleben, Ralph Stephan, Ruf, Tobias Friedrich, Kipperman, Robert M., Rassi, Andrew N., Szerlip, Molly, Goldman, Scott, Inglessis-Azuaje, Ignacio, Yadav, Pradeep, Lurz, Philipp, Davidson, Charles J., Mumtaz, Mubashir, Gada, Hemal, Kar, Saibal, Kodali, Susheel K., Laham, Roger, Hiesinger, William, Fam, Neil P., Keßler, Mirjam, O’Neill, William W., Whisenant, Brian, Kliger, Chad, Kapadia, Samir, Rudolph, Volker, Choo, Joseph, Hermiller, James, Morse, Michael A., Schofer, Niklas, Gafoor, Sameer, Latib, Azeem, Mahoney, Paul, Kaneko, Tsuyoshi, Shah, Pinak B., Riddick, John A., Muhammad, Kamran I., Boekstegers, Peter, Price, Matthew J., Praz, Fabien, Koulogiannis, Konstantinos, Marcoff, Leo, Hausleiter, Jörg, and Lim, D. Scott

Published
2023
Full Text
View/download PDF

12. 1-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study Results

Author

Zahr, Firas, Song, Howard K., Chadderdon, Scott, Gada, Hemal, Mumtaz, Mubashir, Byrne, Timothy, Kirshner, Merick, Sharma, Samin, Kodali, Susheel, George, Isaac, Merhi, William, Yarboro, Leora, Sorajja, Paul, Bapat, Vinayak, Bajwa, Tanvir, Weiss, Eric, Thaden, Jeremy J., Gearhart, Elizabeth, Lim, Scott, Reardon, Michael, Adams, David, Mack, Michael, and Leon, Martin B.

Published
2023
Full Text
View/download PDF

14. Transcatheter Left Ventricular Restoration in Patients With Heart Failure

Author

Hamid, NADIRA, JORDE, ULRICH P., REISMAN, MARK, LATIB, AZEEM, LIM, D. SCOTT, JOSEPH, SUSAN M., KURLIANSKAYA, ALENA, POLONETSKY, OLEG, NEUZIL, PETR, REDDY, VIVEK, FOERST, JASON, GADA, HEMAL, GRUBB, KENDRA J., SILVA, GUILHERME, KEREIAKES, DEAN, SHREENIVAS, SATYA, PINNEY, SEAN, DAVIDAVICIUS, GIEDRIUS, SORAJJA, PAUL, BOEHMER, JOHN P., KLEBER, FRANZ X., PERIER, PATRICK, VAN MIEGHEM, NICOLAS M., DUMONTEIL, NICOLAS, LEON, MARTIN B., and BURKHOFF, DANIEL

Published
2023
Full Text
View/download PDF

15. Clinical Impact of Standardized TAVR Technique and Care Pathway: Insights From the Optimize PRO Study

Author

Grubb, Kendra J., Gada, Hemal, Mittal, Suneet, Nazif, Tamim, Rodés-Cabau, Josep, Fraser, Douglas G.W., Lin, Lang, Rovin, Joshua D., Khalil, Ramzi, Sultan, Ibrahim, Gardner, Blake, Lorenz, David, Chetcuti, Stanley J., Patel, Nainesh C., Harvey, James E., Mahoney, Paul, Schwartz, Brian, Jafar, Zubair, Wang, John, Potluri, Srinivasa, Vora, Amit N., Sanchez, Carlos, Corrigan, Amy, Li, Shuzhen, and Yakubov, Steven J.

Published
2023
Full Text
View/download PDF

17. Randomized Comparison of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation in Prohibitive Surgical Risk Patients

Author

Lim, D. Scott, Smith, Robert L., Gillam, Linda D., Zahr, Firas, Chadderdon, Scott, Makkar, Raj, von Bardeleben, Ralph Stephan, Kipperman, Robert M., Rassi, Andrew N., Szerlip, Molly, Goldman, Scott, Inglessis-Azuaje, Ignacio, Yadav, Pradeep, Lurz, Philipp, Davidson, Charles J., Mumtaz, Mubashir, Gada, Hemal, Kar, Saibal, Kodali, Susheel K., Laham, Roger, Hiesinger, William, Fam, Neil P., Keßler, Mirjam, O’Neill, William W., Whisenant, Brian, Kliger, Chad, Kapadia, Samir, Rudolph, Volker, Choo, Joseph, Hermiller, James, Morse, Michael A., Schofer, Niklas, Gafoor, Sameer, Latib, Azeem, Koulogiannis, Konstantinos, Marcoff, Leo, and Hausleiter, Jörg

Published
2022
Full Text
View/download PDF

18. Aortic Annulus S-Curve: Implications for Transcatheter Aortic Valve Replacement and Related Procedures, Part 1

Author

Zgheib, Ali, Campens, Laurence, Abualsaud, Ali, Al Isma’ili, Abdullah, Barbanti, Marco, Dvir, Danny, Gada, Hemal, Granada, Juan F., Latib, Azeem, Leipsic, Jonathon, Maisano, Francesco, Martucci, Giuseppe, Medina de Chazal, Horacio A., Modine, Thomas, Mylotte, Darren, Prendergast, Bernard, Sawaya, Fadi, Spaziano, Marco, Tang, Gilbert, Theriault-Lauzier, Pascal, Tchetche, Didier, van Mieghem, Nicolas, Søndergaard, Lars, De Backer, Ole, and Piazza, Nicolo

Published
2022
Full Text
View/download PDF

19. Feasibility of Coronary Access Following Redo-TAVR for Evolut Failure: A Computed Tomography Simulation Study

Author

Tang, Gilbert H.L., Spencer, Julianne, Rogers, Toby, Grubb, Kendra J., Gleason, Patrick, Gada, Hemal, Mahoney, Paul, Dauerman, Harold L., Forrest, John K., Reardon, Michael J., Blanke, Philipp, Leipsic, Jonathon A., Abdel-Wahab, Mohamed, Attizzani, Guilherme F., Puri, Rishi, Caskey, Michael, Chung, Christine J., Chen, Ying-Hwa, Dudek, Dariusz, Allen, Keith B., Chhatriwalla, Adnan K., Htun, Wah Wah, Blackman, Daniel J., Tarantini, Giuseppe, Zhingre Sanchez, Jorge, Schwartz, Greta, Popma, Jeffrey J., and Sathananthan, Janarthanan

Published
2023
Full Text
View/download PDF

20. Combined left atrial appendage occlusion and catheter ablation procedure for left atrial arrhythmias: A real‐world, propensity‐matched analysis.

Author

Preisendörfer, Stefan, Ayub, Muhammad T., Sheth, Aakash, Jabbour, George Y., Singh, Madhurmeet, Patel, Chinmay P., Gada, Hemal, Bhonsale, Aditya, Dhande, Mehak, Estes, Nathan A., Kancharla, Krishna, Kliner, Dustin E., Makani, Amber, Naniwadekar, Aditi, Shalaby, Alaa, Singla, Virginia, Voigt, Andrew, Saba, Samir F., and Jain, Sandeep K.

Subjects
TRANSESOPHAGEAL echocardiography, ANTICOAGULANTS, MYOCARDIAL infarction, LEFT heart atrium, PATIENT safety, T-test (Statistics), BODY mass index, VENTRICULAR ejection fraction, PULMONARY veins, PROBABILITY theory, FISHER exact test, SEX distribution, HYPERTENSION, TREATMENT effectiveness, RETROSPECTIVE studies, DESCRIPTIVE statistics, ANGIOGRAPHY, AGE distribution, LONGITUDINAL method, CHRONIC kidney failure, ATRIAL fibrillation, ATRIAL arrhythmias, COMBINED modality therapy, ELECTRONIC health records, MEDICAL records, ACQUISITION of data, INTERNATIONAL normalized ratio, LEFT atrial appendage closure, CATHETER ablation, COMPARATIVE studies, PLATELET aggregation inhibitors, DATA analysis software, CORONARY artery disease, STROKE, ALCOHOL drinking, FLUOROSCOPY, DIABETES, NOSEBLEED, DRUG utilization
Abstract

Introduction: Real‐world studies comparing safety and efficacy of combined percutaneous left atrial appendage occlusion (LAAO) and catheter ablation (CA) to LAAO alone are limited. Methods: Patients from a large US hospital system undergoing combined LAAO and left‐atrial CA from 8/2020 to 2/2024 were retrospectively analyzed and compared to a control group undergoing LAAO alone. Controls were identified using a 1:2 propensity score match based on LAAO device type (Watchman FLX vs. Amulet), CHA2D2‐VASc and Hypertension, Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile international normalized ratio [INR], Elderly, Drugs/alcohol (HAS‐BLED) scores and compared for safety, sealing performance and clinical outcomes at 6 months. Results: Patients were younger in the combined (n = 72) than in the control group (n = 144, 70.2 ± 7.3 vs. 76.7 ± 6.9 years, p < 0.001) but otherwise comparable with a mean CHA2D2‐VASc score of 4.2 ± 1.1 and 4.4 ± 1.2 (p = 0.26) and HAS‐BLED score of 2.2 ± 0.8 and 2.3 ± 0.7 (p = 0.34). Successful LAAO implantation rates were the same (95.8% vs. 95.8%, p = 0.99) with longer procedure times seen in the combined group (156.5 ± 53 vs. 56 ± 26 min, p < 0.001). Both major (1.4% vs. 2.1%, p = 0.72) and minor (27.8% vs. 19.4%, p = 0.17) in‐hospital complications were similar between the combined and control group, respectively. At 45 days, presence of peri‐device leak (18.3% vs. 30.4%, p = 0.07) and device related thrombosis (4.5% vs. 4.5%, p = 0.96) on transesophageal echocardiogram did not differ. Finally, all‐cause mortality (0% vs. 1.4%, p = 0.99), thromboembolic (0% vs. 0%, p = 0.99) and bleeding (6.1% vs. 4.4%, p = 0.73) events during follow‐up were comparable. Conclusion: This large, real‐world analysis indicates comparable safety and efficiency of combined LAAO and CA when compared with LAAO alone. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

21. Transcatheter Aortic Valve Implantation by Valve Type in Women With Small Annuli: Results From the SMART Randomized Clinical Trial.

Author

Tchétché, Didier, Mehran, Roxana, Blackman, Daniel J., Khalil, Ramzi F., Möllmann, Helge, Abdel-Wahab, Mohamed, Ben Ali, Walid, Mahoney, Paul D., Ruge, Hendrik, Bleiziffer, Sabine, Lin, Lang, Szerlip, Molly, Grubb, Kendra J., Byku, Isida, Guerrero, Mayra, Gillam, Linda D., Petronio, Anna Sonia, Attizzani, Guilherme F., Batchelor, Wayne B., and Gada, Hemal

Published
2024
Full Text
View/download PDF

23. Balloon-Expandable Valve for Treatment of Evolut Valve Failure: Implications on Neoskirt Height and Leaflet Overhang

Author

Akodad, Mariama, Sellers, Stephanie, Landes, Uri, Meier, David, Tang, Gilbert H.L., Gada, Hemal, Rogers, Toby, Caskey, Michael, Rutkin, Bruce, Puri, Rishi, Rovin, Joshua, Leipsic, Jonathon, Sondergaard, Lars, Grubb, Kendra J., Gleason, Patrick, Garde, Kshitija, Tadros, Hatem, Teodoru, Sebastian, Wood, David A., Webb, John G., and Sathananthan, Janarthanan

Published
2022
Full Text
View/download PDF

24. Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut study.

Author

Dvir, Danny, Tchétché, Didier, Leon, Martin B, Généreux, Philippe, Seguy, Benjamin, Makkar, Raj, Pibarot, Philippe, Gada, Hemal, Nazif, Tamim, Hildick-Smith, David, Kempfert, Jörg, Dumonteil, Nicolas, Unbehaun, Axel, Modine, Thomas, Whisenant, Brian, Caussin, Christophe, Conradi, Lenard, Waggoner, Thomas, Mishell, Jacob M, and Chetcuti, Stanley J

Subjects
BIOPROSTHETIC heart valves, AORTIC valve, HEART valves, ARTERIAL occlusions, TREATMENT effectiveness
Abstract

Background and Aims This trial sought to assess the safety and efficacy of ShortCut, the first dedicated leaflet modification device, prior to transcatheter aortic valve implantation (TAVI) in patients at risk for coronary artery obstruction. Methods This pivotal prospective study enrolled patients with failed bioprosthetic aortic valves scheduled to undergo TAVI and were at risk for coronary artery obstruction. The primary safety endpoint was procedure-related mortality or stroke at discharge or 7 days, and the primary efficacy endpoint was per-patient leaflet splitting success. Independent angiographic, echocardiographic, and computed tomography core laboratories assessed all images. Safety events were adjudicated by a clinical events committee and data safety monitoring board. Results Sixty eligible patients were treated (77.0 ± 9.6 years, 70% female, 96.7% failed surgical bioprosthetic valves, 63.3% single splitting and 36.7% dual splitting) at 22 clinical sites. Successful leaflet splitting was achieved in all [100%; 95% confidence interval (CI) 94%–100.0%, P <.001] patients. Procedure time, including imaging confirmation of leaflet splitting, was 30.6 ± 17.9 min. Freedom from the primary safety endpoint was achieved in 59 [98.3%; 95% CI (91.1%–100%)] patients, with no mortality and one (1.7%) disabling stroke. At 30 days, freedom from coronary obstruction was 95% (95% CI 86.1%–99.0%). Within 90 days, freedom from mortality was 95% [95% CI (86.1%–99.0%)], without any cardiovascular deaths. Conclusions Modification of failed bioprosthetic aortic valve leaflets using ShortCut was safe, achieved successful leaflet splitting in all patients, and was associated with favourable clinical outcomes in patients at risk for coronary obstruction undergoing TAVI. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

25. 3-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study.

Author

Zahr, Firas, Ramlawi, Basel, Reardon, Michael J., Deeb, G. Michael, Yakubov, Steven J., Song, Howard K., Kleiman, Neal S., Chetcuti, Stanley J., Gada, Hemal, Mumtaz, Mubashir, Leung, Stephane, Merhi, William, Rovin, Joshua D., DeFrain, Michael, Muppala, Murali, Kauten, James, Rajagopal, Vivek, Huang, Jiang, Ito, Saki, and Forrest, John K.

Abstract

Outcomes from transcatheter aortic valve replacement (TAVR) in low–surgical risk patients with bicuspid aortic stenosis beyond 2 years are limited. This study aimed to evaluate 3-year clinical and echocardiographic outcomes from the Evolut Low Risk Bicuspid Study. The Evolut Low Risk Bicuspid Study is a prospective, multicenter, single-arm study conducted in 25 U.S. centers. Patients with severe aortic stenosis at low surgical risk with bicuspid aortic valve anatomy (all subtypes) underwent TAVR with a self-expanding, supra-annular Evolut R or PRO (Medtronic) bioprosthesis. An independent clinical events committee adjudicated all deaths and endpoint-related adverse events, and a central echocardiographic core laboratory assessed hemodynamic endpoints. An attempted implant was performed in 150 patients from December 2018 to October 2019. The mean age was 70.3 ± 5.5 years, 48% (72/150) of the patients were women, and the mean Society of Thoracic Surgeons Predicted Risk of Mortality score was 1.3% (Q1-Q3: 0.9%-1.7%). Sievers type 1 was the dominant bicuspid morphology (90.7%, 136/150). The Kaplan-Meier rates of all-cause mortality or disabling stroke were 1.3% (95% CI: 0.3%-5.3%) at 1 year, 3.4% (95% CI: 1.4%-8.1%) at 2 years, and 4.1% (95% CI: 1.6%-10.7%) at 3 years. The incidence of new permanent pacemaker implantation was 19.4% (95% CI: 12.4%-29.6%) at 3 years. There were no instances of moderate or severe paravalvular aortic regurgitation at 2 and 3 years after TAVR. The 3-year results from the Evolut Low Risk Bicuspid Study demonstrate low rates of all-cause mortality or disabling stroke and favorable hemodynamic performance. [Display omitted] [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

27. Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients.

Author

Kleiman, Neal S., Van Mieghem, Nicolas M., Reardon, Michael J., Gada, Hemal, Mumtaz, Mubashir, Olsen, Peter Skov, Heiser, John, Merhi, William, Chetcuti, Stanley, Deeb, G. Michael, Chawla, Atul, Kiaii, Bob, Teefy, Patrick, Chu, Michael W.A., Yakubov, Steven J., Windecker, Stephan, Althouse, Andrew D., and Baron, Suzanne J.

Abstract

Symptomatic patients with severe aortic stenosis (AS) at high risk for surgical aortic valve replacement (SAVR) sustain comparable improvements in health status over 5 years after transcatheter aortic valve replacement (TAVR) or SAVR. Whether a similar long-term benefit is observed among intermediate-risk AS patients is unknown. The purpose of this study was to assess health status outcomes through 5 years in intermediate risk patients treated with a self-expanding TAVR prosthesis or SAVR using data from the SURTAVI (Surgical Replacement and Transcatheter Aortic Valve Implantation) trial. Intermediate-risk patients randomized to transfemoral TAVR or SAVR in the SURTAVI trial had disease-specific health status assessed at baseline, 30 days, and annually to 5 years using the Kansas City Cardiomyopathy Questionnaire (KCCQ). Health status was compared between groups using fixed effects repeated measures modelling. Of the 1,584 patients (TAVR, n = 805; SAVR, n = 779) included in the analysis, health status improved more rapidly after TAVR compared with SAVR. However, by 1 year, both groups experienced large health status benefits (mean change in KCCQ-Overall Summary Score (KCCQ-OS) from baseline: TAVR: 20.5 ± 22.4; SAVR: 20.5 ± 22.2). This benefit was sustained, albeit modestly attenuated, at 5 years (mean change in KCCQ-OS from baseline: TAVR: 15.4 ± 25.1; SAVR: 14.3 ± 24.2). There were no significant differences in health status between the cohorts at 1 year or beyond. Similar findings were observed in the KCCQ subscales, although a substantial attenuation of benefit was noted in the physical limitation subscale over time in both groups. In intermediate-risk AS patients, both transfemoral TAVR and SAVR resulted in comparable and durable health status benefits to 5 years. Further research is necessary to elucidate the mechanisms for the small decline in health status noted at 5 years compared with 1 year in both groups. (Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement [SURTAVI]; NCT01586910) [Display omitted] [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

30. TAVR in Intermediate-Risk Patients: 5-Year Outcomes From the SURTAVI Continued Access Study

Author

Mahoney, Paul, primary, Newton, Joseph, additional, Gada, Hemal, additional, Mumtaz, Mubashir, additional, Williams, Mathew, additional, Waksman, Ron, additional, Bafi, Ammar, additional, Fail, Peter, additional, Netherland, Donald, additional, Davis, Thomas, additional, Batra, Sanjay, additional, Chhim, Rothy, additional, Verdoliva, Sarah, additional, and Reardon, Michael J., additional

Published
2023
Full Text
View/download PDF

32. Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High Risk

Author

O'Hair, Daniel, Yakubov, Steven J., Grubb, Kendra J., Oh, Jae K., Ito, Saki, Deeb, G. Michael, Van Mieghem, Nicolas M., Adams, David H., Bajwa, Tanvir, Kleiman, Neal S., Chetcuti, Stanley, Søndergaard, Lars, Gada, Hemal, Mumtaz, Mubashir, Heiser, John, Merhi, William M., Petrossian, George, Robinson, Newell, Tang, Gilbert H.L., Rovin, Joshua D., Little, Stephen H., Jain, Renuka, Verdoliva, Sarah, Hanson, Tim, Li, Shuzhen, Popma, Jeffrey J., Reardon, Michael J., O'Hair, Daniel, Yakubov, Steven J., Grubb, Kendra J., Oh, Jae K., Ito, Saki, Deeb, G. Michael, Van Mieghem, Nicolas M., Adams, David H., Bajwa, Tanvir, Kleiman, Neal S., Chetcuti, Stanley, Søndergaard, Lars, Gada, Hemal, Mumtaz, Mubashir, Heiser, John, Merhi, William M., Petrossian, George, Robinson, Newell, Tang, Gilbert H.L., Rovin, Joshua D., Little, Stephen H., Jain, Renuka, Verdoliva, Sarah, Hanson, Tim, Li, Shuzhen, Popma, Jeffrey J., and Reardon, Michael J.

Abstract

Importance: The frequency and clinical importance of structural valve deterioration (SVD) in patients undergoing self-expanding transcatheter aortic valve implantation (TAVI) or surgery is poorly understood. Objective: To evaluate the 5-year incidence, clinical outcomes, and predictors of hemodynamic SVD in patients undergoing self-expanding TAVI or surgery. Design, Setting, and Participants: This post hoc analysis pooled data from the CoreValve US High Risk Pivotal (n = 615) and SURTAVI (n = 1484) randomized clinical trials (RCTs); it was supplemented by the CoreValve Extreme Risk Pivotal trial (n = 485) and CoreValve Continued Access Study (n = 2178). Patients with severe aortic valve stenosis deemed to be at intermediate or increased risk of 30-day surgical mortality were included. Data were collected from December 2010 to June 2016, and data were analyzed from December 2021 to October 2022. Interventions: Patients were randomized to self-expanding TAVI or surgery in the RCTs or underwent self-expanding TAVI for clinical indications in the nonrandomized studies. Main Outcomes and Measures: The primary end point was the incidence of SVD through 5 years (from the RCTs). Factors associated with SVD and its association with clinical outcomes were evaluated for the pooled RCT and non-RCT population. SVD was defined as (1) an increase in mean gradient of 10 mm Hg or greater from discharge or at 30 days to last echocardiography with a final mean gradient of 20 mm Hg or greater or (2) new-onset moderate or severe intraprosthetic aortic regurgitation or an increase of 1 grade or more. Results: Of 4762 included patients, 2605 (54.7%) were male, and the mean (SD) age was 82.1 (7.4) years. A total of 2099 RCT patients, including 1128 who received TAVI and 971 who received surgery, and 2663 non-RCT patients who received TAVI were included. The cumulative incidence of SVD treating death as a competing risk was lower in patients undergoing TAVI than surgery (TAVI, 2.20%; sur

Published
2023

33. LB-8 | Performance and Use of the Evolut FX Transcatheter Aortic Valve System: Updated Results from the Evolut FX Limited Market Release Clinical Survey

Author

Bajwa, Tanvir K., primary, Attizzani, Guilherme, additional, Gada, Hemal, additional, Chetcuti, Stanley J., additional, Williams, Mathew Rulon, additional, Ahmed, Mustafa, additional, Petrossian, George A., additional, Saybolt, Matthew Douglas, additional, Lambrecht, Larry, additional, and Tang, Gilbert, additional

Published
2023
Full Text
View/download PDF

34. 3-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis

Author

Forrest, John K., primary, Deeb, G. Michael, additional, Yakubov, Steven J., additional, Gada, Hemal, additional, Mumtaz, Mubashir A., additional, Ramlawi, Basel, additional, Bajwa, Tanvir, additional, Teirstein, Paul S., additional, DeFrain, Michael, additional, Muppala, Murali, additional, Rutkin, Bruce J., additional, Chawla, Atul, additional, Jenson, Bart, additional, Chetcuti, Stanley J., additional, Stoler, Robert C., additional, Poulin, Marie-France, additional, Khabbaz, Kamal, additional, Levack, Melissa, additional, Goel, Kashish, additional, Tchétché, Didier, additional, Lam, Ka Yan, additional, Tonino, Pim A.L., additional, Ito, Saki, additional, Oh, Jae K., additional, Huang, Jian, additional, Popma, Jeffrey J., additional, Kleiman, Neal, additional, Reardon, Michael J., additional, Sorajja, Paul, additional, Byrne, Timothy, additional, Kirshner, Merick, additional, Crouch, John, additional, Coselli, Joseph, additional, Silva, Guilherme, additional, Hebeler, Robert, additional, Stoler, Robert, additional, Islam, Ashequl, additional, Rousou, Anthony, additional, Bladergroen, Mark, additional, Fail, Peter, additional, Netherland, Donald, additional, Tonino, W.A.L., additional, Sudre, Arnaud, additional, Berthoumieu, Pierre, additional, Khalili, Houman, additional, Hughes, G. Chad, additional, Harrison, J Kevin, additional, De, Ajanta, additional, Tsau, Pei, additional, van Mieghem, Nicolas M., additional, Larbalestier, Robert, additional, Yong, Gerald, additional, Agarwal, Shikhar, additional, Martin, William, additional, Park, Steven, additional, Reardon, Michael, additional, Mohammadi, Siamak, additional, Rodes-Cabau, Josep, additional, Sparling, Jeffrey, additional, Elkins, C. Craig, additional, Ganzel, Brian, additional, Matthews, Ray V., additional, Starnes, Vaughn A., additional, Ando, Kenji, additional, Chevalier, Bernard, additional, Farge, Arnaud, additional, Combs, William, additional, Bagur, Rodrigo, additional, Chu, Michael, additional, Fontana, Gregory, additional, Dev, Visha, additional, Leya, Ferdinand, additional, Tuchek, J. Michael, additional, Inglessis, Ignacio, additional, Jassar, Arminder, additional, Piazza, Nicolo, additional, Lacappelle, Kevin, additional, Steinberg, Daniel, additional, Katz, Marc, additional, Wang, John, additional, Kozina, Joseph, additional, Slachman, Frank, additional, Merritt, Robert, additional, Jensen, Bart, additional, Alvarez, Jorge, additional, Gooley, Robert, additional, Smith, Julian, additional, Ibrahim, Reda, additional, Cartier, Raymond, additional, Rovin, Joshua, additional, Fujita, Tomoyuki, additional, Rutkin, Bruce, additional, Yakubov, Steven, additional, Song, Howard, additional, Zahr, Firas, additional, Miyagawa, Shigeru, additional, Rajagopal, Vivek, additional, Kauten, James, additional, Mumtaz, Mubashir, additional, Bhindi, Ravinay, additional, Brady, Peter, additional, Batra, Sanjay, additional, Davis, Thomas, additional, Iskander, Ayman, additional, Heimansohn, David, additional, Hermiller, James, additional, Takamisawa, Itaru, additional, Haldis, Thomas, additional, Yamazaki, Seiji, additional, Teirstein, Paul, additional, Tada, Norio, additional, Saito, Shigeru, additional, Merhi, William, additional, Leung, Stephane, additional, Muller, David, additional, Heijmen, Robin, additional, Petrossian, George, additional, Robinson, Newell, additional, Knight, Peter, additional, Ling, Frederick, additional, Radhakrishnan, Sam, additional, Fremes, Stephen, additional, Lehr, Eric, additional, Gafoor, Sameer, additional, Noel, Thomas, additional, Walton, Antony, additional, Resar, Jon, additional, Adams, David, additional, Sharma, Samin, additional, Lilly, Scott, additional, Tadros, Peter, additional, Zorn, George, additional, Dauerman, Harold, additional, Ittleman, Frank, additional, Horlick, Erik, additional, Feindel, Chris, additional, Welt, Frederick, additional, Sharma, Vikas, additional, Markowitz, Alan, additional, Carroll, John, additional, Fullerton, David, additional, Griffith, Bartley, additional, Gupta, Anuj, additional, de Marchena, Eduardo, additional, Salerno, Tomas, additional, Chetcuti, Stanley, additional, Sultan, Ibrahim, additional, Pasupati, Sanjeevan, additional, Kon, Neal, additional, Zhao, David, additional, and Forrest, John, additional

Published
2023
Full Text
View/download PDF

35. Impact of aortic valve replacement in symptomatic low-risk patients with less than severe aortic stenosis

Author

Ito, Saki, primary, Laham, Roger, additional, Nkomo, Vuyisile T, additional, Forrest, John K, additional, Reardon, Michael J, additional, Little, Stephen H, additional, Mumtaz, Mubashir, additional, Gada, Hemal, additional, Bajwa, Tanvir, additional, Langholz, David, additional, Heiser, John, additional, Chawla, Atul, additional, Jenson, Bart, additional, Attizanni, Guilherme, additional, Markowitz, Alan H, additional, Huang, Jian, additional, and Oh, Jae K, additional

Published
2023
Full Text
View/download PDF

36. COMPUTED TOMOGRAPHY TO ASSESS FEASIBILITY OF CORONARY ACCESS FOLLOWING BALLOON-EXPANDABLE VALVE IMPLANTATION WITHIN A SUPRA-ANNULAR TRANSCATHETER VALVE

Author

Rogers, Toby, primary, Spencer, Julianne, additional, Tang, Gilbert Hin-Lung, additional, Grubb, Kendra Janel, additional, Gleason, Patrick, additional, Gada, Hemal, additional, Mahoney, Paul D., additional, Dauerman, Harold L., additional, Forrest, John K., additional, Reardon, Michael J., additional, Abdel-Wahab, Mohamed, additional, Puri, Rishi, additional, Attizzani, Guilherme, additional, Caskey, Michael, additional, Chung, Christine, additional, Chen, Ying-Hwa, additional, Htun, Wah Wah, additional, Sanchez, Jorge Zhingre, additional, Schwartz, Greta, additional, Popma, Jeffrey J., additional, and Sathananthan, Janarthanan, additional

Published
2023
Full Text
View/download PDF

37. BIOPROSTHETIC VALVE FRACTURE IN PATIENTS UNDERGOING SELF-EXPANDING TRANSCATHETER AORTIC VALVE REPLACEMENT IN A FAILED SURGICAL VALVE: REAL-WORLD OUTCOMES FROM THE TRANSCATHETER VALVE THERAPY REGISTRY

Author

Allen, Keith B., primary, Chhatriwalla, Adnan, additional, Bapat, Vinayak Nilkanth, additional, Tang, Gilbert Hin-Lung, additional, Grubb, Kendra Janel, additional, Setty, Sampoornima, additional, Berry, Natalia, additional, Zahr, Firas E., additional, Garcia, Santiago, additional, Reardon, Michael J., additional, Webb, John G., additional, Sathananthan, Janarthanan, additional, Vora, Amit N., additional, Eisenberg, Ruth, additional, and Gada, Hemal, additional

Published
2023
Full Text
View/download PDF

39. Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High Risk

Author

O’Hair, Daniel, primary, Yakubov, Steven J., additional, Grubb, Kendra J., additional, Oh, Jae K., additional, Ito, Saki, additional, Deeb, G. Michael, additional, Van Mieghem, Nicolas M., additional, Adams, David H., additional, Bajwa, Tanvir, additional, Kleiman, Neal S., additional, Chetcuti, Stanley, additional, Søndergaard, Lars, additional, Gada, Hemal, additional, Mumtaz, Mubashir, additional, Heiser, John, additional, Merhi, William M., additional, Petrossian, George, additional, Robinson, Newell, additional, Tang, Gilbert H. L., additional, Rovin, Joshua D., additional, Little, Stephen H., additional, Jain, Renuka, additional, Verdoliva, Sarah, additional, Hanson, Tim, additional, Li, Shuzhen, additional, Popma, Jeffrey J., additional, and Reardon, Michael J., additional

Published
2023
Full Text
View/download PDF

40. CRT-700.03 TAVR in Intermediate-Risk Patients: 5-Year Outcomes From the SURTAVI Continued Access Study

Author

Mahoney, Paul, primary, Newton, Joseph, additional, Gada, Hemal, additional, Mumtaz, Mubashir, additional, Williams, Mathew, additional, Waksman, Ron, additional, Bafi, Ammar, additional, Fail, Peter, additional, Netherland, Donald, additional, Davis, Thomas, additional, Batra, Sanjay, additional, Chhim, Rothy, additional, Verdoliva, Sarah, additional, and Reardon, Michael J., additional

Published
2023
Full Text
View/download PDF

45. Balloon-Expandable Valve for Treatment of Evolut Valve Failure: Implications on Neo-Skirt Height and Leaflet Overhang

Author

Akodad, Mariama, primary, Sellers, Stephanie, additional, Landes, Uri, additional, Meier, David, additional, Tang, Gilbert H.L., additional, Gada, Hemal, additional, Rogers, Toby, additional, Caskey, Michael, additional, Rutkin, Bruce, additional, Puri, Rishi, additional, Rovin, Joshua, additional, Leipsic, Jonathon, additional, Sondergaard, Lars, additional, Grubb, Kendra J., additional, Gleason, Patrick, additional, Garde, Kshitija, additional, Tadros, Hatem, additional, Teodoru, Sebastian, additional, Wood, David A., additional, Webb, John G., additional, and Sathananthan, Janarthanan, additional

Published
2022
Full Text
View/download PDF

46. Effect of COVID-19 Surveillance Testing on Patient Perceptions in Outpatients Undergoing Cardiovascular Procedures: Results From the Restoring Non-Emergent Cardiovascular Care in the Peri-COVID-19 Era (RECIPE) Registry

Author

Bruening, Stephen, primary, Vora, Amit, additional, Gada, Hemal, additional, Patel, Chinmay, additional, Schmidt, Torrey, additional, Hubbard, C. Randy, additional, Chang, David, additional, Aladham, Ahmed, additional, and Bachinsky, William, additional

Published
2022
Full Text
View/download PDF

50. Characterization of Cerebral Embolic Capture Using the SENTINEL Device During Transcatheter Aortic Valve Implantation in Low to Intermediate-Risk Patients: The SENTINEL-LIR Study

Author

Kawakami, Rika, primary, Gada, Hemal, additional, Rinaldi, Michael J., additional, Nazif, Tamim M., additional, Leon, Martin B., additional, Kapadia, Samir, additional, Krishnaswamy, Amar, additional, Sakamoto, Atsushi, additional, Sato, Yu, additional, Mori, Masayuki, additional, Kawai, Kenji, additional, Cornelissen, Anne, additional, Park, Ji-Eun, additional, Ghosh, Saikat Kumar B., additional, Abebe, Biniyam G., additional, Romero, Maria, additional, Virmani, Renu, additional, and Finn, Aloke V., additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results